🚀 ProPicks AI Hits +34.9% Return!Read Now

Micron, Lexicon Pharmaceuticals And Some Other Big Stocks Moving Lower In Today's Pre-Market Session

Published 22/12/2022, 12:46
© Reuters Micron, Lexicon Pharmaceuticals And Some Other Big Stocks Moving Lower In Today's Pre-Market Session
MU
-
IXIC
-
LXRX
-

Benzinga - U.S. stock futures traded lower this morning. Here are some big stocks recording losses in today’s pre-market trading session.

  • Westrock Coffee Company, LLC (NASDAQ: WEST) shares tumbled 10.9% to $11.90 in pre-market trading after gaining 10% on Wednesday.
  • Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) tumbled 8.4% to $1.74 in pre-market trading after the company reported topline results from Phase 2 proof-of-concept study of LX9211 in postherpetic neuralgia. The company said primary endpoint was not met.
  • Opendoor (NASDAQ:OPEN) Technologies Inc. (NASDAQ: OPEN) shares dipped 7.8% to $1.05 in pre-market trading after dropping around 10% on Wednesday.
  • Taboola.com Ltd. (NASDAQ: TBLA) declined 6% to $2.50 in pre-market trading after gaining 5% on Wednesday.

Don’t forget to check out our premarket coverage here

  • trivago N.V. (NASDAQ: TRVG) dropped 4.5% to $1.27 in pre-market trading.
  • IAMGOLD Corporation (NYSE: IAG (LON:ICAG)) fell 3.8% to $2.26 in pre-market trading.
  • IAMGOLD recently announced a transaction with Sumimoto Metal Mining to provide up to $340 million in additional funding to the contruction of the Côté Gold Project.
  • Inovio Pharmaceuticals, Inc. (NASDAQ: INO) fell 3.6% to $1.61 in pre-market trading.
  • Micron Technology (NASDAQ:MU), Inc. (NASDAQ: MU) dropped 2.9% to $49.70 in pre-market trading after the company reported downbeat results for its first quarter and issued weak earnings forecast for the second quarter. The company also announced plans to lay off 10% of its workforce next year.

Check This Out: Market Volatility Drops Further Following Rebound In US Consumer Confidence .

© 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.